poisar

Stocks · News reference

Reported Earlier, ADARx Pharmaceuticals Prices Upsized Initial Public Offering Of 26,250,000 Common Shares At $17.00 Per Share, Raising $446.3M

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ADRX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — ADARx Pharmaceuticals, Inc. (ADRX)

    Filed: 2026-09-28 AccNo: 0001193125-26-405297 Size: 193 KB Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    ADRX